Daiichi Sankyo and its 15.000 employees in more than 20 countries are dedicated to the creation and supply of innovative pharmaceutical products. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology. Our European headquarters are in Munich, Germany and we have affiliates in 13 European countries including Denmark, where Copenhagen acts as the Nordic headquarter.
For our headquarter in Munich we are seeking highly qualified candidates to fill the position:
Senior Manager Clinical Safety Scientist (m/f/x)
The Senior Manager, Clinical Safety Scientist, will handle aspects of signal identification, evaluation, and risk mitigation across therapeutic areas, in collaboration with product safety leads. This position proactively creates communication plans for important safety topics and identified risks. This position may serve as primary author for certain safety documents and regulatory submissions (NDA/BLA in US and MAA in EU). Additionally, this position project manages larger Phase 3 Studies, Safety Management Team (SMT) meetings and supervises junior scientist to work together as a team. This position works closely with CSPV staff, SMT members and other functions.
Roles and responsibilities:
Oncology Product Risk Management support for pivotal clinical studies and BLA/MAA activities
Risk Management (Signal identification, evaluation, mitigation) and Safety Communication
Project Management
We offer an interesting, diversified and challenging position, good contractual conditions, flexible working models, all the social benefits of a modern company and a professional environment where you will have the opportunity for personal growth.
We are looking forward to your application.
For more information: www.daiichi-sankyo.eu.